Predictors of mortality among patients with community-onset infection due to extended-spectrum β-lactamase producing Escherichia coli in Thailand

被引：13

作者：

Apisarnthanarak, Anucha ^{[1
]}

Kiratisin, Patarachai ^{[2
]}

Saifon, Piyawan ^{[2
]}

Kitphati, Rungrueng ^{[3
]}

Dejsirilert, Surang ^{[3
]}

Mundy, Linda M. ^{[4
]}

机构：

[1] Thammasart Univ Hosp, Fac Med, Div Infect Dis, Pathum Thani 12120, Thailand

[2] Mahidol Univ, Fac Med, Siriraj Hosp, Dept Microbiol, Bangkok 10700, Thailand

[3] Thai Natl Inst Hlth, Div Sci, Nonthaburi, Thailand

[4] St Louis Univ, Sch Publ Hlth, St Louis, MO 63103 USA

来源：

INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY | 2008年 / 29卷 / 01期

关键词：

D O I：

10.1086/524321

中图分类号：

R1 [预防医学、卫生学];

学科分类号：

1004 ; 120402 ;

摘要：

A matched case-control study was performed to identify predictors of mortality among patients (n = 46) with community-onset in fections due to extended-spectrum beta-lactamase-producing Escherichia coli in Thailand. The crude mortality rate was 30%. By multivariable analysis, community-onset bloodstream infection due to extended-spectrum b-lactamase-producing E. coli was the sole predictor of mortality (adjusted odds ratio, 41.3 [95% confidence interval, 4.3-69.4]; P = .001).

引用

页码：80 / 82

页数：3

共 10 条

[1] Clinical and molecular epidemiology of community-onset, extendedspectrum β-lactamase-producing Escherichia coli infections in Thailand:: A case-case-control study [J].

Apisarnthanarak, Anucha ;

Kiratisin, Patarachai ;

Saifon, Piyawan ;

Kitphati, Rungrueng ;

Dejsirilert, Surang ;

Mundy, Linda M. .

AMERICAN JOURNAL OF INFECTION CONTROL, 2007, 35 (09) :606-612

[2] Inappropriate antibiotic use in a tertiary care center in thailand: An incidence study and review of experience in Thailand [J].

Apisarnthanarak, Anucha ;

Danchaivijitr, Somwang ;

Bailey, Thomas C. ;

Fraser, Victoria J. .

INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY, 2006, 27 (04) :416-420

[3] Risk factors for community-onset urinary tract infections due to Escherichia coli harbouring extended-spectrum β-lactamases [J].

Calbo, E ;

Romaní, V ;

Xercavins, M ;

Gómez, L ;

Vidal, CG ;

Quintana, S ;

Vila, J ;

Garau, J .

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2006, 57 (04) :780-783

[4]

CLSI, 2006, PERF STAND ANT SUSC

[5] Risk factors for the development of extended-spectrum beta-lactamase-producing bacteria in nonhospitalized patients [J].

Colodner, R ;

Rock, W ;

Chazan, B ;

Keller, N ;

Guy, N ;

Sakran, W ;

Raz, R .

EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2004, 23 (03) :163-167

[6]

DEJSIRILERT S, 2004, 9 W PAC C CHEM INF D, P185

[7] CDC DEFINITIONS FOR NOSOCOMIAL INFECTIONS, 1988 [J].

GARNER, JS ;

JARVIS, WR ;

EMORI, TG ;

HORAN, TC ;

HUGHES, JM .

AMERICAN JOURNAL OF INFECTION CONTROL, 1988, 16 (03) :128-140

[8] Control-group selection importance in studies of antimicrobial resistance:: Examples applied to Pseudomonas aeruginosa, enterococci, and Escherichia coli [J].

Harris, AD ;

Samore, MH ;

Lipsitch, M ;

Kaye, KS ;

Perencevich, E ;

Carmeli, Y .

CLINICAL INFECTIOUS DISEASES, 2002, 34 (12) :1558-1563

[9] Inadequate antimicrobial treatment: An important determinant of outcome for hospitalized patients [J].

Kollef, MH .

CLINICAL INFECTIOUS DISEASES, 2000, 31 :S131-S138

[10] Bacteremia due to extended-spectrum β-lactamase producing Escherichia coli in the CTX-M era:: A new clinical challenge [J].

Rodriguez-Bano, Jesus ;

Navarro, Maria D. ;

Romero, Luisa ;

Muniain, Miguel A. ;

de Cueto, Marina ;

Rios, Maria J. ;

Hernandez, Jose R. ;

Pascual, Alvaro .

CLINICAL INFECTIOUS DISEASES, 2006, 43 (11) :1407-1414

← 1 →